- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04783324
The Effect of the E-Mobile Health Application on Postpartum Adaptation
The Effect of the E-Mobile Health Application for Pregnant Women Created Based on the Roy's Adaptation Model on Postpartum Adaptation
Study Overview
Status
Intervention / Treatment
Detailed Description
This is a randomized controlled trial. A questionnaire and The Postpartum Self-Evaluation Questionnaire will be used to collect data. The main hypothesis of the research: Postpartum Self-Evaluation Questionnaire total mean score of women who use e-mobile health application created according to Roy's Adaptation Model is not different from the total mean score of women in the control group.
Research sample will consist of a total of 62 pregnant women, 31 in the experimental group and 31 in the control group. The data will be evaluated with the SPSS (Statistical Package of SocialSciences) 24.0 package program.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Ankara, Turkey
- Ankara Koru Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Primiparous
- Being in the 32nd week of pregnancy and above
- Not getting any diagnosis that poses a risk for pregnancy (Multiple pregnancy, Gestational Diabetes, Preeclampsia, Eclampsia, Placenta Previa, Fetal Anomaly, Intrauterine Growth Retardation)
- Speaking Turkish
- To be at least a primary school graduate
- Having a smart phone with Android operating system
Exclusion Criteria:
- Multiparous
- Being under 32 weeks of pregnancy
- Getting any diagnosis that poses a risk to pregnancy (Multiple pregnancy, Gestational Diabetes, Preeclampsia, Eclampsia, Placenta Previa, Fetal Anomaly, Intrauterine Growth Retardation)
- Not speaking Turkish
- Having a smartphone with an operating system other than Android
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Experimental Group
Pregnant women in the intervention group will use the e-mobile health application developed by the researcher.
|
The e-mobile health application prepared by the researcher will be used.
E-mobile health application include information about postpartum care.
|
No Intervention: Control Group
Pregnant women in the control group will not be intervened and standard care will be applied.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Postpartum Adaptation
Time Frame: At postpartum tenth day (baseline) and last-interview at postpartum sixth week (change from baseline at sixth week)
|
Postpartum adaptation according to Postpartum Self Evaluation Scale.
Postpartum self evaluation questionnaire consists of 82 questions in total.
The questions are scored between 1 and 4 points.
The minimum value that can be obtained from the scale is 82, the maximum value is 328.
It is seen that the lower the score in this scale, the higher the postpartum adaptaion of the individual.
|
At postpartum tenth day (baseline) and last-interview at postpartum sixth week (change from baseline at sixth week)
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Şengül Yaman Sözbir, PhD, Gazi University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- SultanOzkan
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pregnant Women
-
Myant Medical Corp.McMaster UniversityNot yet recruiting
-
Qianfoshan HospitalShandong Nursing AssociationRecruiting
-
Brigham and Women's HospitalEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsRecruitingPregnant WomenUnited States
-
Sultan Abdulhamid Han Training and Research Hospital...RecruitingPregnant WomenTurkey
-
Sultan Abdulhamid Han Training and Research Hospital...Not yet recruiting
-
Alexandria UniversityCompleted
-
University of BeykentIstanbul University - Cerrahpasa (IUC)Completed
-
Anhui Provincial HospitalAalto UniversityCompleted
-
Assistance Publique - Hôpitaux de ParisCompleted
Clinical Trials on E-Mobile Health Application
-
San Diego State UniversityRecruitingObesity | Diabetes Mellitus, Type 2United States
-
Vanderbilt University Medical CenterOhio State UniversityActive, not recruitingSickle Cell DiseaseUnited States
-
San Diego State UniversityRecruitingObesity | Diabetes Mellitus, Type 2United States
-
University of CadizCompleted
-
University of LincolnLincolnshire Partnership NHS Foundation TrustCompletedPsychological DistressUnited Kingdom
-
Hospital Clinic of BarcelonaCompletedChronic Disease | Multiple Chronic ConditionsSpain
-
University of California, San FranciscoNational Institute of Mental Health (NIMH)CompletedHIV/AIDS | Mobile Health | Young AdultsUnited States
-
University of California, Los AngelesCompletedContraception | Mobile Applications | Contraception BehaviorUnited States
-
University of MinnesotaCompletedHealthy Children (1 Month to 17 Years Old)United States